Sustaining agbiotechnology through lean times

Nature Biotechnology

Volumn 21, Issue 9, 2003, Pages 996-1002

  McElroy, David ^a  

^a Verdia Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTELLECTUAL PROPERTY; LAWS AND LEGISLATION;

LIFE SCIENCE;

BIOTECHNOLOGY;

BACILLUS THURINGIENSIS; COMMERCIAL PHENOMENA; CONSUMER; CROP PEST; CROP PRODUCTION; ECONOMIC EVALUATION; FINANCIAL MANAGEMENT; INSECT CONTROL; MARKETING; PHENOTYPE; PLANT BIOTECHNOLOGY; PLANT BREEDING; PLANT GROWTH; PLANT PEST; PRIORITY JOURNAL; REVIEW;

AGRICULTURE; BIOTECHNOLOGY; CAPITAL FINANCING; DRUG INDUSTRY; INVESTMENTS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

BACILLUS THURINGIENSIS; INSECTA;

EID: 0042861541     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0903-996     Document Type: Review

References (19)

1. Gompers, P.A. & Lerner, J. The Money of Invention (Harvard Business School Press, Boston, MA, 2001).
2. Weck, E. The transgenic plant market: profits from new products and novel drugs (Drug & market development report no. 9070) (Westborough, MA, 2002).
3. Andersson, R. & Mynahan, R. The protein production challenge. In Vivo: The Business and Medicine Report 5, 1-5 (2001).
4. McElroy, D. Moving agbiotech downstream. Nat. Biotechnol. 17, 1071-1074 (1999).
5. Myers, S.C. & Howe, C.D. A life-cycle financial model of pharmaceutical R&D (MIT Program On the Pharmaceutical Industry working paper no. 41-97) (MIT Sloan School of Management, Cambridge, MA, 1997).
6. , Demasi, J.A., Hansen, R.W. & Grabowski, H.G. The price of innovation: new estimates for drug development costs. J. Health Economics 22, 151-185 (2003).
7. Fischhoff, B. & Fischhoff, I. Publics' opinions about biotechnologies. AgBioForum 4, 155-162 (2001).
8. Gianessi, L.P., Silvers, C.S., Sanuka, S. & Carpenter, J.E. Plant biotechnology: current and potential impact for improving pest management in U.S. agriculture (National Center for Food & Agricultural Policy, Washington, DC, 2002).
9. Marra, M.C., Pardey, P.G. & Alston, J.M. The payoffs to transgenic field crops: an assessment of the evidence. AgBioForum 5, 43-50 (2002).
10. Agricultural Biotechnology in Europe. Economic impact of crop biotechnology (Issue Paper 5) http://www.abeurope.info/images/files/abe_issues_paper_5.pdf (AgBiotech Europe, 2002.
11. Agricultural Biotechnology in Europe. The environmental impact of agricultural biotechnology (Issue Paper 3) (AgBiotech Europe, 2002).
12. Carson, D.D, Agricultural chemicals report (Merrill Lynch Research & Economics Group, New York, NY, 2002).
13. Graff, G.D., Rausser, G.C. & Small, A.A. Agricultural biotechnology's complementary intellectual assets. Rev. Econ. Stats. 85, 349-363 (2003).
14. Brennan, M.F. Pray C.E. & Courtmanche, A. in Transitions in Agbiotech: Economics of Strategy and Policy, Ch. 8 (ed. Lesser, W.H.) 153-174 (Food Marketing Policy Center, Storrs, CT, 2002).
15. Fulton, M. & Konstantinos, G. Agriculturai biotechnology and industry structure. AgBioForum 4, 137-151 (2001).
16. Phillips, P.W,B, & Corkindale, D. Marketing GM foods: the way forward. AgBioForum 5, 113-121 (2003).
17. Graff, G.D. & Newcomb, J. Agricultural biotechnology at the crossroads. (Bio-Era report) http://www.bio-era.net/be_index.php (Bio Economic Research Associates, Cambridge, MA, 2003).
18. Plant Genetic Systems v. Dekalb Genetics Corp., 2003 U.S. App. LEXIS 447 [Fed. Cir, Feb. 20, 2003).
19. Atkinson, R.C. et al. Public sector collaboration for agricultural IP management. Science 301, 174-175 (2003).